@article {Desmarais748, author = {Julianna Desmarais and Cong-Qiu Chu}, title = {Utility of Anakinra in Acute Crystalline Diseases: A Retrospective Study Comparing a University Hospital with a Veterans Affairs Medical Center}, volume = {46}, number = {7}, pages = {748--750}, year = {2019}, doi = {10.3899/jrheum.180393}, publisher = {The Journal of Rheumatology}, abstract = {Objective. To evaluate the efficacy and safety of anakinra in inpatient management of acute gout and pseudogout.Methods. Hospitalized patients with acute gout (n = 77) or pseudogout (n = 11) or both (n = 3) were analyzed for response to anakinra and adverse effects.Results. Half of all patients had comorbidities limiting the treatment choice. Anakinra was well tolerated, and 92\% of gout flares and 79\% of pseudogout flares responded to treatment.Conclusion. Anakinra is an effective and safe treatment for acute gout and pseudogout in hospitalized patients, particularly in those with comorbidities.}, issn = {0315-162X}, URL = {https://www.jrheum.org/content/46/7/748}, eprint = {https://www.jrheum.org/content/46/7/748.full.pdf}, journal = {The Journal of Rheumatology} }